Mercury Pharmaceuticals

We are de-risking biomedical innovations, while turning biomedical knowledge into social and economic value.

Stay Informed!

Chronic liver disease threatens millions across Europe, report finds

25

May 2026

Chronic liver disease threatens millions across Europe, report finds

Europe is facing a growing chronic liver disease threat, according to a new Series published today in The Lancet Regional Health – Europe, that engaged more than 75 co-authors from 30 countries and was led by the Barcelona Institute for Global Health (ISGlobal), an institution supported by the "la Caixa" Foundation.

DNA metabarcoding reveals hidden freshwater biodiversity in Ontario streams

25

May 2026

DNA metabarcoding reveals hidden freshwater biodiversity in Ontario streams

Researchers using cutting-edge environmental DNA (eDNA) technology have uncovered far greater biodiversity in eastern Ontario waterways than traditional monitoring methods detected over more than a decade, demonstrating the transformative potential of DNA-based biomonitoring for freshwater conservation and environmental management.

Indian adapted Mediterranean diet targets inflammation in heart disease trial

25

May 2026

Indian adapted Mediterranean diet targets inflammation in heart disease trial

The paper describes a single-center randomized controlled trial testing whether an Indian Adapted Mediterranean Diet can reduce dietary inflammation in adults with stable coronary artery disease or moderate-to-high cardiovascular risk. The protocol will assess changes in the Dietary Inflammatory Index, inflammatory biomarkers, cardiometabolic risk factors, body measurements, and metabolic hormones over six months.

Antarctic mission study reveals how constant proximity increases team conflict

25

May 2026

Antarctic mission study reveals how constant proximity increases team conflict

Space missions expose crews to months of isolation, confinement and extreme stress. An international study led by Jan Schmutz, professor at the Department of Psychology at the University of Zurich, and Andrea Cantisani, psychiatrist and research associate at the University of Bern, has investigated how such conditions affect team dynamics during a ten-month overwintering mission at Concordia Station in Antarctica.

MERCURY trials

Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more

Cancer

Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more

Neuroscience

Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more

Mercury Pharmaceuticals

Why Us?

Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator.
Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry.
Smart approach to project management that helps speed up development stages and decision making.
Availability of own investment up to 2m€ per project allows us to reach the next value milestone.